By Swati Pandey
SYDNEY (Reuters) - Asian shares firmed on Monday on renewed hopes for a coronavirus vaccine after AstraZeneca resumed its phase-3 trial though sentiment was still cautious ahead of a big week of central bank meetings in UK, Japan and the United States.
MSCI's broadest index of Asia-Pacific shares outside Japan was up 0.7%, poised for its second straight session of gains.
Australian shares climbed 0.6% while Japan's Nikkei added 0.
7%. Chinese shares started firm with the blue-chip index rising 0.6%.